X·CON 2019 – Healthtech →
June 21st, 2015
Bluebird Bio (NASDAQ: BLUE) hired former Sangamo Biosciences (NASDAQ: SGMO) chief scientific officer and research chief Phillip Gregory as its new CSO.
Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at email@example.com Follow @benthefidler
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Whitepaper
Remain compliant and ensure optimal productivity
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Xconomy Insight · Webinar
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Tax credits help tech innovators attract capital, fuel growth
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.